IASLC 2019 Mesothelioma Meeting
July 10-12, 2019 | New York, New York


This IASLC meeting is designed to provide information about ongoing clinical trials of the newest therapies for mesothelioma. The meeting presenters summarize the data on relevant targets for new therapies. Data on preclinical and early clinical data are presented for each of the drugs directed against these targets. The meeting also presents data on early predictive biomarkers.  

There are also presentations from fellows and young investigators in training and debates about controversial topics. The meeting is a unique resource for clinical investigators, including those in academia, clinical practice and industry. 

What you should expect to learn

  • Provide a forum for clinical mesothelioma investigators to understand the science behind emerging therapies; and
  • Recognize and plan the most novel and relevant scientific trials of new therapies.

Important Dates

Regular registration closes on June 28. Register before the deadline to save up to USD 500!

(deadline June 28, 2019)

(deadline after June 28, 2019)

IASLC Member



IASLC Non-Member



IASLC Member - Student, Trainee, Resident



IASLC Non-Member - Student, Trainee, Resident












  • Medical oncologists
  • Thoracic surgeons
  • Pulmonologists
  • Radiation oncologists
  • Radiologists
  • Pathologists
  • Advanced practice nurses and physicians' assistants.
Westin New York at Times Square
270 W. 43rd Street
New York, NY, USA 10036

Official Hotel Website


Member Experience Department